Skip to main content
. 2017 Aug 4;12(8):e0181960. doi: 10.1371/journal.pone.0181960

Table 5. Severity of depressive disorders in HIV-infected adults evaluated by the Beck Depression Inventory (BDI).

First Author, year by chronological order Country Study years HIV+ N HIV- N Demographic data Clinical data Tools Main results or Prevalence (%) (95% CI)
Age (years) Men (%) Education level (%) CD4 cell count /mm3 CDC/WHO stage (%) ART (%)
BDI 13 items
Amberbir et al, 2008 [58] Ethiopia 2006–2007 400 NA • 30**
• Range
• 19–58
40.3% Secondary 50.3% CD4<200: 72.2%
• WHO 3/4: 66.3% / 24.8%
100% Cut-off ≥10 • At baseline: 55.8%
• At follow-up: 49.6%
BDI 21 items
Kagee et al, 2013 [59] South Africa NA 200 NS 34.05 (7.6)* 21% • Secondary: 65.3%
• Tertiary: 7.1%
NA NA 100% • Moderate 17–30
• Severe ≥31
• Moderate 28.5%
• Severe 16.2%
Nel et al, 2013 [9] South Africa NA 101 NA 35.04 (7.05)* 17.8% NA NA NA 100% • Mild 14–19
• Moderate 20–28
• Severe 29–63
• Mild 11.7%
• Moderate 22.3%
• Severe 18.1%
Kagee et al, 2010 [60] South Africa NA 85 NS 32.8 (7.6)*  24.7% • Secondary: 10%
• Tertiary: 90%
NA NA yes/no • Mild 10–18
• Moderate 19–29
• Severe 30–63
• Mild 24.7%
• Moderate 20%
• Severe 17.6%
Lawler et al, 2011 [39] Bostwana 2008 120 NA 37.5 (6.5)* 50% • Secondary: 48%
• Tertiary: 15%
360.4 (181.4)* CD4<200: 20% NA 97.5% • Fast screen 7 items
• Cut-off ≥4
38% (mild: 59%; moderate: 27%; severe: 14%)

Abbreviations: ART: Antiretroviral Therapy; CI: Confidence Interval; IQR: InterQuartile Range; NA: Not available; SD: Standard Deviation.

*Mean (SD)

** Median (IQR)

NB: Articles are presented in function of ART status of included patients